Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Q1 2025 Earnings Call Transcript April 29, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $1.16, ...

BLACKSBURG, Va. (WDBJ) - Earlier this year, the Food and Drug Administration (FDA) banned the use of Red No.3 dye. This is ...

The webcast of the presentation will be accessible in the Investor section of the Actuate website. The Actuate management ...

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with Trump order on gender.

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...

The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight ...